Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Omer Zaidi's publication output changed over time?
ScholarIQpublication output · 2018–2024
Output grew300% over the shown period — from 1 works in 2018 to 4 in 2024.
1
4
1
4
2018202120222024
What are the most-cited papers on Omer Zaidi?
ScholarIQmost cited works
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction
Stephen J. Greene, Xi Tan, Yu‐Chen Yeh, Mark Bernauer, Omer Zaidi, Mei Yang, Javed Butler
S82077098. 202140 Citations
Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries
Omer Zaidi, Fen Du, Zhaoli Tang, Sandipan Bhattacharjee, Kristin Pareja
BMC Nephrology. 202423 CitationsOPEN ACCESS
The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)
Esther Natalie Olíva, Jacob Franek, Dipen Patel, Omer Zaidi, Salem Abi Nehme, António Almeida
Blood. 201817 Citations
Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas
Terapong Tantawichien, Li Yang Hsu, Omer Zaidi, Mark Bernauer, Frieda Du, Eriko Yamada, Jin Oh Kim, Isaya Sukarom
S163950488. 202113 Citations
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data
Jingyan Yang, Rongzhe Liu, A. Granghaud, Omer Zaidi, Jennifer Stephens
Journal of Medical Economics. 202110 CitationsOPEN ACCESS
Related on ScholarIQ
The Open Group
Institution
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction
Paper
Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries
Paper
The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)
Paper
Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas
Paper
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data
Paper